EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical

Qing Tang1, Ying Yang2, Jia'nan Sun3

  • 1Department of Gynecology, Yantai Yuhuangding Hospital, No.20, Yuhuangding East Road, Yantai, 264000, China.

Human Cell
|June 19, 2025
PubMed

Insights

Enhancer of zeste homolog 2 (EZH2) inhibition suppresses tumor growth in HPV16-positive cervical cancer by regulating KDM6A and M2 macrophage polarization. This finding offers insights into immune modulation strategies for cervical cancer treatment.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • High-risk human papillomavirus (HPV) subtypes influence the immune response in cervical cancer.
  • Tumor-associated macrophages (TAMs) play a crucial role in tumor development by modulating the immune response.
  • The role of enhancer of zeste homolog 2 (EZH2) in TAM-mediated immune regulation within HPV16-positive cervical cancer requires elucidation.

Purpose of the Study:

  • To investigate the mechanism by which EZH2 influences TAMs in HPV16-positive cervical cancer.
  • To analyze the impact of EZH2 inhibition on KDM6A expression, inflammatory responses, and M2 macrophage polarization in HPV16-positive cervical cancer cells.
  • To evaluate the therapeutic potential of EZH2 inhibition in reducing tumor growth in vivo.

Main Methods:

  • HPV16-positive cervical cancer cell lines (SiHa, CaSki) were treated with an EZH2 inhibitor (EPZ6438).
  • KDM6A expression, cell viability, inflammatory cytokine levels (IL-6, CXCL1), and Akt signaling were assessed.
  • M2 macrophage polarization was studied via co-culture experiments, and tumor growth was evaluated in a nude mouse model.

Main Results:

  • EZH2 inhibition suppressed cell viability and inflammatory responses by downregulating KDM6A in HPV16-positive cervical cancer cells.
  • Overexpression of KDM6A counteracted the effects of EZH2 inhibition on cell viability and inflammation.
  • EZH2 inhibition reduced M2 macrophage polarization, linked to KDM6A-mediated inflammatory responses, and decreased tumor growth in vivo.

Conclusions:

  • EZH2 inhibition exerts anti-tumor effects in HPV16-positive cervical cancer by suppressing KDM6A and modulating the inflammatory response.
  • The mechanism involves KDM6A-mediated regulation of inflammatory pathways, impacting M2 macrophage polarization and subsequent tumor growth.
  • EZH2 inhibition represents a potential therapeutic strategy for HPV16-positive cervical cancer through immune modulation.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K